ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36685
0.00%
Bitcoin
63,176.76
-1.12%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Transgene SA (TNG)

  7. Transgene SA (TNG) News

TNG

Transgene (TNG)

Transgene SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:TNG
DateTimeSourceHeadlineSymbolCompany
04/24/202410:45AMGlobeNewswire Inc.Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024EU:TNGTransgene SA
04/24/202410:45AMGlobeNewswire Inc.Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024EU:TNGTransgene SA
04/24/202410:45AMGlobeNewswire Inc.Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai 2024EU:TNGTransgene SA
04/11/202412:05PMGlobeNewswire Inc.Document d'enregistrement Universel 2023EU:TNGTransgene SA
04/11/202410:45AMGlobeNewswire Inc.Availability of Transgene's 2023 Universal Registration DocumentEU:TNGTransgene SA
04/11/202410:45AMGlobeNewswire Inc.MIse à disposition du document d'enregistrement universel 2023 de TransgeneEU:TNGTransgene SA
04/09/202410:45AMGlobeNewswire Inc.Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024EU:TNGTransgene SA
04/09/202410:45AMGlobeNewswire Inc.Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024EU:TNGTransgene SA
04/09/202410:45AMGlobeNewswire Inc.Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024EU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources OfficerEU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025EU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025EU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources OfficerEU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources HumainesEU:TNGTransgene SA
03/27/202411:45AMGlobeNewswire Inc.Transgene prévoit des avancées significatives sur son portefeuille d’immunothérapies en 2024 et étend sa visibilité financière jusqu’au 4ème trimestre 2025EU:TNGTransgene SA
03/18/202411:45AMGlobeNewswire Inc.Transgene annonce ses prochaines rencontres avec les investisseursEU:TNGTransgene SA
03/18/202411:45AMGlobeNewswire Inc.Transgene Announces Upcoming Investor MeetingsEU:TNGTransgene SA
03/18/202411:45AMGlobeNewswire Inc.Transgene Announces Upcoming Investor MeetingsEU:TNGTransgene SA
03/06/202412:30AMGlobeNewswire Inc.Transgene présentera de nouvelles données sur son vaccin individualisé TG4050 à l’AACR 2024EU:TNGTransgene SA
03/06/202412:30AMGlobeNewswire Inc.Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024EU:TNGTransgene SA
03/06/202412:30AMGlobeNewswire Inc.Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024EU:TNGTransgene SA
03/05/202412:30AMGlobeNewswire Inc.Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050EU:TNGTransgene SA
03/05/202412:30AMGlobeNewswire Inc.Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050EU:TNGTransgene SA
03/05/202412:30AMGlobeNewswire Inc.Transgene, NEC et BostonGene étendent leur collaboration dans le cadre de l’essai clinique de Phase I/II du vaccin individualisé TG4050EU:TNGTransgene SA
01/22/202410:45AMGlobeNewswire Inc.Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business OfficerEU:TNGTransgene SA
01/22/202410:45AMGlobeNewswire Inc.Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business OfficerEU:TNGTransgene SA
01/22/202410:45AMGlobeNewswire Inc.Transgene annonce la nomination de James Wentworth comme Directeur du Business DevelopmentEU:TNGTransgene SA
01/22/20241:00AMGlobeNewswire Inc.Transgene Announces Financial Calendar for 2024EU:TNGTransgene SA
01/22/20241:00AMGlobeNewswire Inc.Transgene Announces Financial Calendar for 2024EU:TNGTransgene SA
01/22/20241:00AMGlobeNewswire Inc.Transgene présente son calendrier de communication financière pour 2024EU:TNGTransgene SA
 Showing the most relevant articles for your search:EU:TNG

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
ZHUD
Zhuding (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
CGAC
Code Green Apparel (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KEGS
1812 Brewing (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
COOP
Mr Cooper
USOTC
IFUS
Impact Fusion (PK)
NYSE
AMC
AMC Entertainment
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved